Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yongpeng Tong
A Novel EGFR-TKI Inhibitor (cAMP-H3BO3 Complex) Combined With Thermal Therapy Is a Promising Strategy to Improve Lung Cancer Treatment Outcomes
Oncotarget
Oncology
Related publications
Continued EGFR -TKI With Concurrent Radiation Therapy to Improve Time to Progression in Patients With Locally Progressive Non–small Cell Lung Cancer After Front-Line EGFR -TKI Treatment
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Combined Therapy With EGFR TKI and Gambogic Acid for Overcoming Resistance in EGFR‑T790M Mutant Lung Cancer
Oncology Letters
Cancer Research
Oncology
Differentiation Therapy: A Promising Strategy for Cancer Treatment
Chinese Journal of Cancer
P3.01-60 a Novel MET D1246H Mutation After Progression of EGFR-TKI/MET Inhibitor Combined Therapy in a NSCLC Patient With Acquired MET Amplification
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Phase 1 Trial of Dasatinib Combined With Afatinib for Epidermal Growth Factor Receptor- (EGFR-) Mutated Lung Cancer With Acquired Tyrosine Kinase Inhibitor (TKI) Resistance
British Journal of Cancer
Cancer Research
Oncology
P2.13-38 Impact of Tyrosine Kinase Inhibitor (TKI) Dose on Outcomes of Patients With Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Comparing the Efficacy of Concurrent EGFR-TKI and Whole-Brain Radiotherapy vs EGFR-TKI Alone as a First-Line Therapy for Advanced EGFR-mutated Non-Small-Cell Lung Cancer With Brain Metastases: A Retrospective Cohort Study
Cancer Management and Research
Oncology
Nimotuzumab Combined With Chemotherapy Is a Promising Treatment for Locally Advanced and Metastatic Esophageal Cancer
Medical Science Monitor
Medicine
Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
Molecular Cancer Therapeutics
Cancer Research
Oncology
